Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Mar;37(3):197–202. doi: 10.1136/jmg.37.3.197

Why do women attend familial breast cancer clinics?

K Brain 1, J Gray 1, P Norman 1, E Parsons 1, A Clarke 1, C Rogers 1, R Mansel 1, P Harper 1
PMCID: PMC1734549  PMID: 10699056

Abstract

The increasing demand for genetic assessment for familial breast cancer has necessitated the development of cancer genetics services. However, little is known about the factors motivating the client population likely to approach these services. A cross sectional questionnaire survey of 1000 women with a family history of breast cancer was conducted to identify self-reported reasons for attending a familial breast cancer clinic and possible differences in the characteristics of women who were attending for diverse reasons. Before attendance at clinic, 833 women completed a baseline questionnaire (83% response rate). Women who gave personal risk (n=188), awareness of a family history (n=120), risk to family members (n=84), reassurance (n=69), genetic testing (n=65), breast screening (n=46), or prevention (n=39) as their main reason for attending were compared on demographic and medical variables, and on psychological variables including general anxiety, cancer worry, perceived risk, and attitudes towards prophylactic surgery and genetic testing. Important differences in the psychological characteristics of these groups were found, which were unrelated to reported family history. In particular, women who primarily wanted genetic testing felt extremely vulnerable to developing breast cancer, were more likely to be considering prophylactic surgery, and perceived fewer limitations of testing. Those who primarily wanted reassurance were highly anxious about the disease. We recommend that cancer genetics services take into consideration the informational and psychological needs and concerns of their client group.


Keywords: familial breast cancer; familial breast cancer clinics; reasons for attending; psychological characteristics

Full Text

The Full Text of this article is available as a PDF (133.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alagna S. W., Morokoff P. J., Bevett J. M., Reddy D. M. Performance of breast self-examination by women at high risk for breast cancer. Women Health. 1987;12(2):29–46. doi: 10.1300/J013v12n02_03. [DOI] [PubMed] [Google Scholar]
  2. Chaliki H., Loader S., Levenkron J. C., Logan-Young W., Hall W. J., Rowley P. T. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health. 1995 Aug;85(8 Pt 1):1133–1135. doi: 10.2105/ajph.85.8_pt_1.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Codori A. M., Slavney P. R., Young C., Miglioretti D. L., Brandt J. Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol. 1997 Jan;16(1):36–50. doi: 10.1037//0278-6133.16.1.36. [DOI] [PubMed] [Google Scholar]
  4. Evans D. G., Burnell L. D., Hopwood P., Howell A. Perception of risk in women with a family history of breast cancer. Br J Cancer. 1993 Mar;67(3):612–614. doi: 10.1038/bjc.1993.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans D. G., Fentiman I. S., McPherson K., Asbury D., Ponder B. A., Howell A. Familial breast cancer. BMJ. 1994 Jan 15;308(6922):183–187. doi: 10.1136/bmj.308.6922.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B., King M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990 Dec 21;250(4988):1684–1689. doi: 10.1126/science.2270482. [DOI] [PubMed] [Google Scholar]
  7. Hallowell N., Murton F., Statham H., Green J. M., Richards M. P. Women's need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study. BMJ. 1997 Jan 25;314(7076):281–283. doi: 10.1136/bmj.314.7076.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Julian-Reynier C., Eisinger F., Chabal F., Aurran Y., Noguès C., Vennin P., Bignon Y. J., Machelard-Roumagnac M., Maugard-Louboutin C., Serin D. Cancer genetics clinics: target population and consultees' expectations. Eur J Cancer. 1996 Mar;32A(3):398–403. doi: 10.1016/0959-8049(95)00601-x. [DOI] [PubMed] [Google Scholar]
  9. Kash K. M., Holland J. C., Halper M. S., Miller D. G. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst. 1992 Jan 1;84(1):24–30. doi: 10.1093/jnci/84.1.24. [DOI] [PubMed] [Google Scholar]
  10. Kessler S., Field T., Worth L., Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet. 1987 Feb;26(2):259–270. doi: 10.1002/ajmg.1320260204. [DOI] [PubMed] [Google Scholar]
  11. Lerman C., Daly M., Masny A., Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994 Apr;12(4):843–850. doi: 10.1200/JCO.1994.12.4.843. [DOI] [PubMed] [Google Scholar]
  12. Lerman C., Hanjani P., Caputo C., Miller S., Delmoor E., Nolte S., Engstrom P. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol. 1992 Feb;10(2):330–333. doi: 10.1200/JCO.1992.10.2.330. [DOI] [PubMed] [Google Scholar]
  13. Lerman C., Narod S., Schulman K., Hughes C., Gomez-Caminero A., Bonney G., Gold K., Trock B., Main D., Lynch J. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996 Jun 26;275(24):1885–1892. [PubMed] [Google Scholar]
  14. Lerman C., Ross E., Boyce A., Gorchov P. M., McLaughlin R., Rimer B., Engstrom P. The impact of mailing psychoeducational materials to women with abnormal mammograms. Am J Public Health. 1992 May;82(5):729–730. doi: 10.2105/ajph.82.5.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lerman C., Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat. 1993 Nov;28(2):145–155. doi: 10.1007/BF00666427. [DOI] [PubMed] [Google Scholar]
  16. Lerman C., Seay J., Balshem A., Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995 Jul 3;57(3):385–392. doi: 10.1002/ajmg.1320570304. [DOI] [PubMed] [Google Scholar]
  17. Lerman C., Trock B., Rimer B. K., Boyce A., Jepson C., Engstrom P. F. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med. 1991 Apr 15;114(8):657–661. doi: 10.7326/0003-4819-114-8-657. [DOI] [PubMed] [Google Scholar]
  18. Lerman C., Trock B., Rimer B. K., Jepson C., Brody D., Boyce A. Psychological side effects of breast cancer screening. Health Psychol. 1991;10(4):259–267. doi: 10.1037//0278-6133.10.4.259. [DOI] [PubMed] [Google Scholar]
  19. Lynch H. T., Watson P., Conway T. A., Lynch J. F., Slominski-Caster S. M., Narod S. A., Feunteun J., Lenoir G. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med. 1993 Sep 13;153(17):1979–1987. [PubMed] [Google Scholar]
  20. Markel D. S., Young A. B., Penney J. B. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet. 1987 Feb;26(2):295–305. doi: 10.1002/ajmg.1320260207. [DOI] [PubMed] [Google Scholar]
  21. Mastromauro C., Myers R. H., Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet. 1987 Feb;26(2):271–282. doi: 10.1002/ajmg.1320260205. [DOI] [PubMed] [Google Scholar]
  22. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  23. Wooster R., Neuhausen S. L., Mangion J., Quirk Y., Ford D., Collins N., Nguyen K., Seal S., Tran T., Averill D. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994 Sep 30;265(5181):2088–2090. doi: 10.1126/science.8091231. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES